Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
10/26/1993 | US5256667 Quinazolinones and pyridopyrimidinones |
10/26/1993 | CA1323728C Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
10/24/1993 | CA2094465A1 Cycloalkane derivatives |
10/24/1993 | CA2094311A1 Method of reducing or preventing toxicity associated with antiretroviral therapy |
10/21/1993 | CA2091400A1 Calpain inhibitor cystamidine a and its production |
10/20/1993 | EP0566542A1 Use of L-carnitine or acyl-L-carnitine in combination with an ACE-inhibitor for producing pharmaceutical composition for the treatment of cardiovascular disorders |
10/20/1993 | EP0566166A1 Chelants possessing ortho ligating functionality and complexes thereof |
10/20/1993 | EP0566158A1 The use of alpha-1-antitrypsin mutants in the manufacture of medicaments, and therapeutic formulations using mutants and their preparation |
10/20/1993 | EP0566020A1 Benzimidazoles, pharmaceutical compositions thereof and processes for their preparation |
10/20/1993 | EP0565896A2 Derivatives of aspartic acid, preparation and use thereof |
10/20/1993 | EP0565658A1 Verbenone, having antielastase activity, against pulmonary emphysema |
10/20/1993 | EP0565642A1 Method of preventing inflammatory damage |
10/20/1993 | EP0565634A1 Angiotensin ii receptor blocking compositions |
10/20/1993 | EP0565582A1 Novel csaids |
10/20/1993 | EP0398925B1 Growth inhibiting agent and the use thereof |
10/20/1993 | EP0356484B1 Process for preparation of aloe products |
10/19/1993 | US5254731 Substituted 3,4-dihydronaphthalenes, pharmaceutical compositions containing them, and preparation processes |
10/19/1993 | US5254715 Anticholesterol agents |
10/19/1993 | US5254682 Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs |
10/19/1993 | US5254680 Elastase inhibitors |
10/19/1993 | US5254594 Remedies for bone diseases |
10/19/1993 | US5254575 4-aryl-thiazole derivatives |
10/19/1993 | US5254570 Acyl derivative of dianhydrohexitols |
10/19/1993 | US5254560 2-piperidinylpyrimidine-4-carboxamide derivatives, and their use in therapeutics |
10/19/1993 | US5254554 Anxiolytic agents |
10/19/1993 | US5254546 Fused aryl substituted imidazole angiotensin II receptor inhibitors |
10/19/1993 | US5254533 Elfamycin |
10/19/1993 | CA1323366C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives |
10/17/1993 | CA2094076A1 Indole derivatives |
10/17/1993 | CA2094075A1 Indole derivatives |
10/17/1993 | CA2094073A1 Indole derivatives |
10/14/1993 | WO1993020202A1 Decorin fragments and methods of inhibiting cell regulatory factors |
10/14/1993 | WO1993020197A1 Stem cell proliferation factor |
10/14/1993 | WO1993020073A1 Indole derivatives as 5-ht1 agonists |
10/14/1993 | WO1993020071A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists |
10/14/1993 | WO1993020066A1 Imidazole, triazole and tetrazole derivatives |
10/14/1993 | WO1993020062A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists |
10/14/1993 | WO1993020057A1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
10/14/1993 | WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors |
10/14/1993 | WO1993019777A1 Fusion proteins comprising tumor necrosis factor receptor |
10/14/1993 | WO1993019769A1 Wound healing and treatment of fibrotic disorders |
10/14/1993 | WO1993019768A1 Self-assembling polynucleotide delivery system |
10/14/1993 | WO1993019755A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | WO1993019750A1 Compounds useful for treating allergic or inflammatory diseases |
10/14/1993 | WO1993019749A1 Compounds useful for treating allergic and inflammatory diseases |
10/14/1993 | WO1993019720A2 Compounds |
10/14/1993 | WO1993019668A1 Method and kit for imaging and treating organs and tissues |
10/14/1993 | WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression |
10/14/1993 | WO1993017118A3 Defective packaging non-oncoviral vectors based on mpmv and hiv |
10/14/1993 | WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
10/14/1993 | DE4212529A1 Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists |
10/14/1993 | CA2133470A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | CA2133460A1 Process for the preparation of 4-pyridyl- and 4-piperidinylimidazoles useful as intermediates for the synthesis of histamine receptor antagonists |
10/14/1993 | CA2133083A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists |
10/14/1993 | CA2133076A1 Imidazole, triazole and tetrazole derivatives |
10/14/1993 | CA2132859A1 Decorin fragments and methods of inhibiting cell regulatory factors |
10/14/1993 | CA2093771A1 Piperazine derivatives |
10/13/1993 | EP0565185A1 Quinoline derivatives as leukotriene antagonists |
10/13/1993 | EP0565135A1 Known and selected novel arylmethylenyl derivatives of imidazolidinones useful as antiallergy agents and antiinflammatory agents |
10/13/1993 | EP0564972A2 Peptides with N-terminal modifications having bradykinin antagonistic activity |
10/13/1993 | EP0564960A1 Imidazopyridines as angiotensin II antagonists |
10/13/1993 | EP0564924A2 2-Oxoethyl derivatives as immunosuppressants |
10/13/1993 | EP0564788A2 Sulfonylbenzyl substituted imidazopyridines as AII-antagonists |
10/13/1993 | EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters |
10/13/1993 | EP0564502A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
10/13/1993 | EP0560937A4 Pharmaceutical compositions |
10/13/1993 | EP0431076B1 Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
10/13/1993 | CN1077202A Peptide mit modifikationen am n-terminus |
10/13/1993 | CN1077195A Sulphonylbenzyl-substituted imidazopyridines |
10/13/1993 | CN1077192A 2-oxoquinoline derivatives |
10/12/1993 | US5252753 Reacting phenyl tetrazole with Grignard reagant; angiotensin receptor antagonist |
10/12/1993 | US5252749 Ethers of thienocyclopentanone oximes, their preparation and pharmaceutical compositions containing them |
10/12/1993 | US5252720 Metal complexes of water soluble texaphyrins |
10/12/1993 | US5252707 Inositol derivative and method for preparing same |
10/12/1993 | US5252604 Compositions of retinoic acids and tocopherol for prevention of dermatitis |
10/12/1993 | US5252592 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
10/12/1993 | US5252581 Substituted aminothienopyridines, pharmaceutical composition and use |
10/12/1993 | US5252560 Cyclic imide derivatives, compositions and use |
10/12/1993 | US5252558 Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions |
10/12/1993 | US5252481 Mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase |
10/12/1993 | CA2093785A1 Benzimidazoles |
10/11/1993 | WO1993020820A1 USE OF β-CARBOLINES |
10/11/1993 | CA2117755A1 Use of .beta.-carbolines |
10/10/1993 | CA2093777A1 Therapeutic amines |
10/10/1993 | CA2093753A1 Hexapaptide |
10/09/1993 | CA2091194A1 2-oxo-ethyl derivatives as immunosuppressants |
10/07/1993 | CA2093290A1 Imidazopyridines |
10/06/1993 | EP0564356A1 4-phenylaminomethylimidazole derivatives, process for their preparation, angiotensin II receptor antagonists and their application in therapy |
10/06/1993 | EP0564307A1 Antiskin rash preparation |
10/06/1993 | EP0564099A1 Alpha-glycosyl derivative of catecholamine or its salt, and its preparation and uses |
10/06/1993 | EP0563705A2 Cycloalkyl- and heterocyclyl substituted imidazolylpropenic acid derivatives |
10/06/1993 | EP0563329A1 Angiogenic peptides |
10/06/1993 | EP0563286A1 Novel csaids |
10/06/1993 | EP0563238A1 Imidazolyl-alkenoic acids |
10/06/1993 | EP0563172A1 Synthetic bioadhesive polypeptide |
10/06/1993 | EP0563107A1 Novel methylenebisphosphonic acid derivatives |
10/06/1993 | EP0563096A1 Novel methylenebisphosphonic acid derivatives |
10/06/1993 | EP0563087A1 Azabicyclic amides or esters of halogenated benzoic acids |
10/06/1993 | CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
10/06/1993 | CN1076929A Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |